50242-0210 Gavreto - CanMED: NDC

Product NDC:

50242-0210

Brand Name:

Gavreto

Generic Name:

Pralsetinib

Dosage Form Name:

CAPSULE

Administration Route:

Oral

Substances:

Name: PRALSETINIB

Strength: 100.0

Unit: mg/1

Packages:

Code: 50242-0210-12

Description: 1 BOTTLE in 1 CARTON (50242-210-12) / 120 CAPSULE in 1 BOTTLE

Effective Date: Sept. 28, 2022

Discontinued:

Code: 50242-0210-60

Description: 1 BOTTLE in 1 CARTON (50242-210-60) / 60 CAPSULE in 1 BOTTLE

Effective Date: July 1, 2021

Discontinued:

Code: 50242-0210-83

Description: 1 BOTTLE in 1 CARTON (50242-210-83) / 60 CAPSULE in 1 BOTTLE

Effective Date: July 1, 2021

Discontinued:

Code: 50242-0210-86

Description: 1 BOTTLE in 1 CARTON (50242-210-86) > 120 CAPSULE in 1 BOTTLE

Effective Date: Sept. 15, 2020

Discontinued: Feb. 11, 2022

Code: 50242-0210-90

Description: 1 BOTTLE in 1 CARTON (50242-210-90) / 90 CAPSULE in 1 BOTTLE

Effective Date: July 1, 2021

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Enzyme Inhibitor

Minor Class:

RET, DDR1, TRKC, FLT3, JAK1/2, TRKA, VEGFR2, PDGFRB, FGFR1

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox